Healthcare transactions are often discussed like traditional middle-market M&A deals. Revenue multiples, EBITDA adjustments, growth rates, and platform expansion strategies dominate most conversations.

In practice, private practice healthcare deals operate differently.

A healthcare practice may produce strong collections and appear highly profitable, yet still present material transaction risk if the revenue is not compliant, transferable, financeable, or sustainable after closing. Buyers, lenders, and investors are not underwriting revenue alone. They are underwriting the durability of cash flow under healthcare regulatory and operational realities.

That distinction drives nearly every successful healthcare transaction.

For brokers, CPAs, lenders, attorneys, investors, and practice owners, the strongest deals are typically the ones where diligence begins early, financial reporting is credible, and operational or regulatory issues are identified before the business goes to market.

Why Healthcare Transactions Are Different

Healthcare businesses operate within a heavily regulated reimbursement environment. Revenue depends on far more than patient demand or operational efficiency.

Key transaction considerations often include:

• Payor reimbursement and billing compliance
• Provider credentialing and enrollment
• Stark Law and Anti-Kickback Statute exposure
• Provider retention and employment continuity
• HIPAA and cybersecurity obligations
• State ownership and corporate practice restrictions
• Payor contract assignment limitations
• Revenue-cycle integrity and documentation quality

In many transactions, the largest risks are not visible in headline EBITDA.

For example, a practice may appear highly profitable, but a buyer or lender may heavily discount value if:

• Add-backs are poorly documented
• Revenue depends on aggressive coding practices
• Financial statements do not reconcile cleanly
• Credentialing delays could interrupt post-closing cash flow
• Compliance infrastructure is weak or undocumented

Healthcare transactions succeed when operational, financial, and regulatory diligence align early in the process.

The Core Issue in Healthcare M&A: Durable Cash Flow

Most healthcare transactions ultimately revolve around one question: Can the business continue producing reliable cash flow after closing?

That is the central concern for buyers, lenders, and investors alike.

Strong historical revenue alone is not enough. Deal participants are evaluating whether the revenue is:

• Consistent
• Collectible
• Recurring
• Properly documented
• Compliant with healthcare laws
• Sustainable after closing

This is why lender underwriting plays such a significant role in healthcare M&A.

Lenders generally focus less on optimistic growth projections and more on historical consistency, provider dependence, reimbursement stability, and normalized earnings quality. Unsupported adjustments or volatile performance trends frequently create financing friction.

A practice with slightly lower but highly consistent earnings will often receive stronger lender support than a practice with higher but uneven performance.

Deal Structure Matters More Than Many Sellers Realize

Healthcare transactions are commonly structured as either asset purchases or equity purchases, but the practical consequences can differ substantially.

Asset purchases

In an asset transaction, the buyer acquires selected assets and assumes selected liabilities.

This structure is often attractive because buyers may limit exposure to certain historical liabilities while receiving favorable tax treatment through a stepped-up asset basis.

However, healthcare asset deals frequently involve additional complexity, including:

• Credentialing delays
• Lease assignment approvals
• Licensing considerations
• Potential interruptions to collections during transition

Equity purchases

In an equity transaction, the buyer acquires ownership interests in the existing entity.

Operational continuity may be smoother because contracts, employees, and licenses often remain with the entity itself. However, buyers generally assume more historical liability risk, which increases the importance of diligence around:

• Billing and coding
• Tax compliance
• Employment classification
• Regulatory investigations
• Overpayment exposure
• Litigation and audit history

MSO and DSO structures

In physician, dental, and veterinary transactions, state corporate practice restrictions frequently shape transaction structure.

Many private equity-backed healthcare platforms operate through management service organization (MSO) or dental service organization (DSO) models, where the professional entity provides clinical services and the management company provides nonclinical administrative support.

These structures require careful attention to:

• Clinical autonomy
• Fee-splitting restrictions
• Fair market value considerations
• Management fee design
• Operational control rights
• State-specific ownership rules

Improper structuring can create material regulatory risk.

EBITDA Is Important — But Credibility Matters More

Adjusted EBITDA remains the primary valuation metric in most healthcare transactions. However, sophisticated buyers and lenders place significant emphasis on the quality and defensibility of adjustments.

Common legitimate add-backs may include:

• Excess owner compensation
• Personal expenses run through the business
• One-time legal or consulting costs
• Nonrecurring recruiting expenses
• Transaction-related expenses

The problem arises when adjustments are unsupported or operationally unrealistic.

Common diligence concerns include:

• Revenue tied to departing providers
• Under-market provider compensation
• Temporary margin improvements
• Unsupported personal expenses
• Deferred operating costs
• Nonrecurring relief funding
• Aggressive revenue assumptions

In healthcare transactions, credibility matters.

Once a buyer, lender, or diligence team loses confidence in financial reporting, valuation pressure usually follows quickly.

Quality of Earnings Is Increasingly Critical

Healthcare buyers and lenders increasingly rely on formal quality of earnings (QofE) reviews before closing.

A healthcare QofE process goes beyond reviewing accounting statements. It often connects financial reporting directly to:

• Billing data
• Collections history
• Payor reports
• AR aging
• Provider productivity
• Denial rates
• Refund and recoupment trends

The primary objective is determining whether reported earnings are sustainable under normalized operating conditions.

Common diligence questions include:

• Do financial statements reconcile to tax returns and deposits?
• Are collections recurring and predictable?
• Are contractual adjustments recorded accurately?
• Are provider compensation models sustainable?
• Are payor contracts current and assignable?
• Are there pending audits or overpayment demands?
• Are billing practices properly documented?

Well-prepared practices generally experience smoother diligence, fewer retrades, and stronger lender confidence.

Regulatory Risk Directly Impacts Value

Healthcare compliance issues are not separate from valuation. They often directly affect purchase price, financing availability, indemnity structure, and closing certainty.

Anti-Kickback Statute and Stark Law

The federal Anti-Kickback Statute (AKS) and Stark Law frequently arise during healthcare diligence.

Areas commonly reviewed include:

• Medical director agreements
• Consulting arrangements
• Space and equipment leases
• Management fees
• Physician compensation structures
• Marketing arrangements
• Joint ventures
• Referral relationships

Buyers and lenders typically focus on whether arrangements are:

• Properly documented
• Commercially reasonable
• Consistent with fair market value
• Operationally supportable
• Structured independently from referral volume

Informal arrangements create substantial diligence concerns.

False Claims Act exposure

False Claims Act risk can arise from:

• Upcoding
• Unsupported billing
• Medical necessity deficiencies
• Improper supervision
• Stark or AKS violations
• Retained overpayments

Diligence teams often review coding audits, denial trends, compliance reporting processes, refund logs, and historical payor disputes to assess exposure.

HIPAA and Cybersecurity

Healthcare diligence also increasingly includes cybersecurity review.

Buyers commonly assess:

• Prior data breaches
• Security risk assessments
• Vendor agreements
• HIPAA policies
• Access controls
• Data-sharing practices
• Cyber insurance coverage

Weak cybersecurity controls are now viewed as operational and financial risks, not merely IT issues.

Provider Retention Often Determines Transaction Stability

Many healthcare practices remain highly dependent on a small number of clinicians.

As a result, provider retention is frequently one of the most important underwriting considerations in the deal.

A business with strong historical collections may still face valuation pressure if:

• Key providers lack enforceable agreements
• Compensation structures are unstable
• Transition plans are unclear
• Clinical leadership is weak
• Provider turnover is elevated

Healthcare revenue is often directly tied to individual relationships, referral patterns, and patient continuity. Buyers and lenders understand this clearly.

Pre-Listing Diligence Creates Better Outcomes

One of the most common transaction mistakes is waiting until buyer diligence to identify major issues.

The strongest healthcare transactions are usually prepared well before the business formally goes to market.

Pre-listing diligence often includes:

• Financial normalization
• EBITDA support schedules
• Tax planning
• Compliance review
• Payor contract analysis
• Provider agreement review
• AR analysis
• Operational risk assessment
• Cybersecurity review
• Credentialing analysis

Preparation does not eliminate every issue. It reduces surprises.

That distinction matters because most failed healthcare transactions do not collapse from one catastrophic problem. They deteriorate from cumulative diligence friction, reduced lender confidence, delayed disclosures, or credibility concerns.

Well-prepared transactions generally move faster because the difficult work has already been done.

The Most Common Healthcare M&A Mistakes

Several issues consistently create transaction problems across healthcare sectors:

• Overstated adjusted EBITDA
• Weak financial reporting
• Informal provider arrangements
• Poorly documented add-backs
• Failure to evaluate payor assignment restrictions
• Inadequate provider retention planning
• Weak compliance infrastructure
• Delayed credentialing analysis
• Insufficient cybersecurity controls
• Lack of integration planning

In many cases, these issues are manageable if identified early.

They become significantly more expensive when discovered late in diligence or during lender review.

Final Thoughts

Healthcare M&A is fundamentally about risk-adjusted cash flow durability.

Strong transactions are rarely defined solely by headline purchase price. They are defined by whether the business can withstand financial, operational, regulatory, and integration scrutiny while maintaining stable post-closing performance.

For sellers, preparation materially affects leverage and transaction certainty.

For buyers, lenders, and investors, disciplined diligence remains essential because healthcare revenue depends on regulatory compliance, provider continuity, and operational execution in ways that ordinary businesses often do not.

The best healthcare transactions are typically the ones where financial, operational, legal, and regulatory diligence are aligned before the market ever sees the deal.

Healthcare transactions move more efficiently when the underlying business is organized, defensible, and diligence-ready from the outset.

To discuss a healthcare transaction, valuation preparation, or pre-listing diligence strategy, schedule a confidential consultation with us today.